NovaBridge Biosciences
NBP
$1.70
-$0.08-4.49%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 190.85M | 190.85M | 210.84M | 228.27M | 165.61M |
| Total Receivables | 5.64M | 5.64M | 1.79M | 926.00K | 784.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.12M | 1.12M | 696.00K | 1.47M | 1.24M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 393.00K | 393.00K | 4.19M | 2.10M | -- |
| Total Current Assets | 198.00M | 198.00M | 217.52M | 232.78M | 167.64M |
|
|
|||||
| Total Current Assets | 198.00M | 198.00M | 217.52M | 232.78M | 167.64M |
| Net Property, Plant & Equipment | 5.61M | 5.61M | 2.95M | 3.17M | 3.38M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.87M | 2.87M | 2.81M | 1.15M | 1.22M |
| Total Assets | 231.54M | 231.54M | 260.52M | 277.41M | 206.71M |
|
|
|||||
| Total Accounts Payable | 4.64M | 4.64M | -- | -- | -- |
| Total Accrued Expenses | 11.13M | 11.13M | 16.82M | 8.03M | 6.49M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.28M | 1.28M | 891.00K | 872.00K | 853.00K |
| Total Finance Division Other Current Liabilities | 8.88M | 8.88M | 9.18M | 7.19M | -- |
| Total Other Current Liabilities | 8.88M | 8.88M | 9.18M | 7.19M | -- |
| Total Current Liabilities | 25.92M | 25.92M | 26.89M | 16.09M | 7.35M |
|
|
|||||
| Total Current Liabilities | 25.92M | 25.92M | 26.89M | 16.09M | 7.35M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.18M | 3.18M | 2.18M | 2.40M | 2.63M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.33M | 1.33M | 511.00K | -- | -- |
| Total Liabilities | 30.44M | 30.44M | 29.58M | 18.50M | 9.98M |
|
|
|||||
| Common Stock & APIC | 1.53B | 1.53B | 1.53B | 1.52B | 1.46B |
| Retained Earnings | -1.37B | -1.37B | -1.33B | -1.30B | -1.29B |
| Treasury Stock & Other | 38.33M | 38.33M | 36.50M | 37.65M | 31.43M |
| Total Common Equity | 201.10M | 201.10M | 230.94M | 258.92M | 196.73M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 201.10M | 201.10M | 230.94M | 258.92M | 196.73M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 201.10M | 201.10M | 230.94M | 258.92M | 196.73M |
|
|
|||||